Ingevity Corporation
NGVT
$40.47
$0.180.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -16.50% | -19.61% | -15.49% | -18.93% | -13.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.50% | -19.61% | -15.49% | -18.93% | -13.37% |
| Cost of Revenue | -29.03% | -34.82% | -22.08% | -18.67% | -8.31% |
| Gross Profit | 13.74% | 36.44% | 0.70% | -19.48% | -23.54% |
| SG&A Expenses | -8.69% | -10.07% | -3.25% | -19.92% | -2.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.92% | -30.91% | -19.85% | -18.64% | -7.73% |
| Operating Income | 38.50% | 116.90% | 4.06% | -20.15% | -38.08% |
| Income Before Tax | 137.27% | 105.71% | -529.60% | -801.47% | -212.17% |
| Income Tax Expenses | 139.62% | 79.03% | -544.93% | -517.21% | -218.66% |
| Earnings from Continuing Operations | 136.61% | 114.21% | -525.40% | -899.15% | -210.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 136.61% | 114.21% | -525.40% | -899.15% | -210.45% |
| EBIT | 38.50% | 116.90% | 4.06% | -20.15% | -38.08% |
| EBITDA | 13.77% | 59.56% | -7.69% | -17.70% | -28.15% |
| EPS Basic | 136.49% | 114.17% | -523.96% | -899.99% | -213.21% |
| Normalized Basic EPS | 1,357.25% | 447.62% | 7.40% | -58.57% | -106.26% |
| EPS Diluted | 136.26% | 114.04% | -527.54% | -905.15% | -214.39% |
| Normalized Diluted EPS | 1,347.64% | 443.13% | 7.89% | -58.32% | -106.33% |
| Average Basic Shares Outstanding | 0.33% | 0.28% | 0.33% | -0.10% | -2.43% |
| Average Diluted Shares Outstanding | 1.10% | 1.10% | -0.12% | -0.72% | -3.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |